top of page
PIPELINE
Creating Transformative Solutions for Patients
ߊ PIPELINE
TRANSMAB® TECHNOLOGY
TARGET
INDICATION
DISCOVERY
PRE-CLINICAL
EARLY CLINICAL
LATE CLINICAL
PARTNERSHIP
TARGET
INDICATION
STATUS
PD-L1
Alzheimer's
Pre-Clinical
PD-L1
Alzheimer's
Undisclosed
Alzheimer's
Discovery
Undisclosed
Neurodegeneration
Discovery
Undisclosed
Alzheimer's
Undisclosed
Neurodegeneration
Internal
Internal
Undisclosed
bottom of page